Cargando…
Oncologist Perspectives on Rare Cancer Care: A Nationwide Survey
PURPOSE: In response to the challenges and difficulties imposed by rare cancers, multi-stakeholder initiatives dedicated to improving rare cancer care was launched, and several recommendations were made by professional societies. However, these primarily reflect the view of the advocates and support...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614206/ https://www.ncbi.nlm.nih.gov/pubmed/25672585 http://dx.doi.org/10.4143/crt.2014.086 |
_version_ | 1782396367374647296 |
---|---|
author | Shin, Dong Wook Cho, Juhee Yang, Hyung Kook Kim, So Young Lee, Su Hyun Suh, Beomseok Shin, Hee-Young Lee, Hyun Joo Kim, Dae Ghon Park, Jong Hyock |
author_facet | Shin, Dong Wook Cho, Juhee Yang, Hyung Kook Kim, So Young Lee, Su Hyun Suh, Beomseok Shin, Hee-Young Lee, Hyun Joo Kim, Dae Ghon Park, Jong Hyock |
author_sort | Shin, Dong Wook |
collection | PubMed |
description | PURPOSE: In response to the challenges and difficulties imposed by rare cancers, multi-stakeholder initiatives dedicated to improving rare cancer care was launched, and several recommendations were made by professional societies. However, these primarily reflect the view of the advocates and supporters, and may not represent the views of the “average” clinician or researcher. In this study, we sought to investigate perceived difficulties with regard to rare cancer care and potential solutions endorsed by oncologists. MATERIALS AND METHODS: A representative sample of 420 oncologists recruited in 13 cancer centers participated in a nationwide survey. RESULTS: Oncologists faced various difficulties in treatment of patients with rare cancers, including the lack of clinical practice guidelines (65.7%) and personal experience (65.2%), lack of approved treatment options (39.8%), and reimbursement issues (44.5%). They were generally supportive of recent recommendations by multi-stakeholder initiatives as well as professional societies for development of clear clinical practice guidelines (66.0%), flexible reimbursement guidelines (52.9%), and a national rare cancer registry (47.4%). However, there was only moderate endorsement for referrals to high-volume centers (35.5%) and encouragement of off-label treatments (21.0%). CONCLUSION: Insights into the general attitudes of oncologists gained through our nationwide survey of representative samples would be helpful in development of clinical practices and public health policies in rare cancer treatment and research. |
format | Online Article Text |
id | pubmed-4614206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Korean Cancer Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-46142062015-10-22 Oncologist Perspectives on Rare Cancer Care: A Nationwide Survey Shin, Dong Wook Cho, Juhee Yang, Hyung Kook Kim, So Young Lee, Su Hyun Suh, Beomseok Shin, Hee-Young Lee, Hyun Joo Kim, Dae Ghon Park, Jong Hyock Cancer Res Treat Original Article PURPOSE: In response to the challenges and difficulties imposed by rare cancers, multi-stakeholder initiatives dedicated to improving rare cancer care was launched, and several recommendations were made by professional societies. However, these primarily reflect the view of the advocates and supporters, and may not represent the views of the “average” clinician or researcher. In this study, we sought to investigate perceived difficulties with regard to rare cancer care and potential solutions endorsed by oncologists. MATERIALS AND METHODS: A representative sample of 420 oncologists recruited in 13 cancer centers participated in a nationwide survey. RESULTS: Oncologists faced various difficulties in treatment of patients with rare cancers, including the lack of clinical practice guidelines (65.7%) and personal experience (65.2%), lack of approved treatment options (39.8%), and reimbursement issues (44.5%). They were generally supportive of recent recommendations by multi-stakeholder initiatives as well as professional societies for development of clear clinical practice guidelines (66.0%), flexible reimbursement guidelines (52.9%), and a national rare cancer registry (47.4%). However, there was only moderate endorsement for referrals to high-volume centers (35.5%) and encouragement of off-label treatments (21.0%). CONCLUSION: Insights into the general attitudes of oncologists gained through our nationwide survey of representative samples would be helpful in development of clinical practices and public health policies in rare cancer treatment and research. Korean Cancer Association 2015-10 2015-01-05 /pmc/articles/PMC4614206/ /pubmed/25672585 http://dx.doi.org/10.4143/crt.2014.086 Text en Copyright © 2015 by the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Shin, Dong Wook Cho, Juhee Yang, Hyung Kook Kim, So Young Lee, Su Hyun Suh, Beomseok Shin, Hee-Young Lee, Hyun Joo Kim, Dae Ghon Park, Jong Hyock Oncologist Perspectives on Rare Cancer Care: A Nationwide Survey |
title | Oncologist Perspectives on Rare Cancer Care: A Nationwide Survey |
title_full | Oncologist Perspectives on Rare Cancer Care: A Nationwide Survey |
title_fullStr | Oncologist Perspectives on Rare Cancer Care: A Nationwide Survey |
title_full_unstemmed | Oncologist Perspectives on Rare Cancer Care: A Nationwide Survey |
title_short | Oncologist Perspectives on Rare Cancer Care: A Nationwide Survey |
title_sort | oncologist perspectives on rare cancer care: a nationwide survey |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614206/ https://www.ncbi.nlm.nih.gov/pubmed/25672585 http://dx.doi.org/10.4143/crt.2014.086 |
work_keys_str_mv | AT shindongwook oncologistperspectivesonrarecancercareanationwidesurvey AT chojuhee oncologistperspectivesonrarecancercareanationwidesurvey AT yanghyungkook oncologistperspectivesonrarecancercareanationwidesurvey AT kimsoyoung oncologistperspectivesonrarecancercareanationwidesurvey AT leesuhyun oncologistperspectivesonrarecancercareanationwidesurvey AT suhbeomseok oncologistperspectivesonrarecancercareanationwidesurvey AT shinheeyoung oncologistperspectivesonrarecancercareanationwidesurvey AT leehyunjoo oncologistperspectivesonrarecancercareanationwidesurvey AT kimdaeghon oncologistperspectivesonrarecancercareanationwidesurvey AT parkjonghyock oncologistperspectivesonrarecancercareanationwidesurvey |